Fast relapse and high drop out rate of 48 weeks daily interferon monotherapy in HIV-infected patients with chronic hepatitis C

BACKGROUND: The standard of care for HCV Hepatitis is the combination of interferon (IFN) plus Ribavirin. In HIV patients the use of this combination therapy may induce drug interactions, and reduces the adherence to HAART. The aim of this study is to evaluate safety and efficacy of a 48 weeks daily...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Bruno, Raffaele, Sacchi, Paolo, Puoti, Massimo, Ciappina, Valentina, Zocchetti, Cristina, Brunetti, Enrico, Maffezzini, Elena, Capelli, Anna, Patruno, Savino FA, Malfitano, Antonello, Filice, Gaetano
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2002
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC128825/
https://ncbi.nlm.nih.gov/pubmed/12199910
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2334-2-17
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki